Dr. Reddy’s Secures Exclusive Rights to Commercialize HLX15 in U.S. & Europe EP News Bureau Feb 6, 2025 HLX15 is a recombinant anti-CD38 fully human monoclonal antibody injection, with intravenous as well as subcutaneous formulations
